-
Product Insights
NewLikelihood of Approval Analysis for Obstructive Sleep Apnea
Overview How likely is it that the drugs in Obstructive Sleep Apnea will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Obstructive Sleep Apnea Overview Obstructive sleep apnea (OSA) is defined by...
-
Product Insights
NewLikelihood of Approval Analysis for Rheumatoid Arthritis
Overview How likely is it that the drugs in Rheumatoid Arthritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rheumatoid Arthritis Overview Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized...
-
Product Insights
NewMicromobility in Insurance – Market Trends and Dynamics, 2024
Micromobility describes the range of lightweight vehicles designed for one or two people. This report examines the growth of micromobility in the UK and Europe. It looks at the types of micromobility vehicle, the services that are offered within the shared and micromobility space, as well as key regulations in major economies around the theme. It then takes a UK focus on insurance implications for owners, users, and renters of micromobility vehicles and finishes with some analysis of key players...
-
Thematic Analysis
NewGeopolitics – Executive Briefing (First Edition)
Reasons to buy the ‘Geopolitics - Executive Briefing’ report: The report provides in-depth insights into the global geopolitical stance. Explore a global geopolitical risk map highlighting level of severity and a summary on the 2024 elections. Identify the frontline sectors exposed to global geopolitics. The report sheds light on the politics of the major countries that shape geopolitics. How is the ‘Geopolitics - Executive Briefing’ report different from other reports in the market? This executive briefing report explores the drivers...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDTX-1535 in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDTX-1535 in Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDTX-1535 in Glioblastoma Multiforme (GBM) Drug Details: BDTX-1535 is under development...
-
Thematic Analysis
NewUkraine Conflict Impact – Thematic Intelligence
Ukraine Conflict Impact Report Overview The large-scale Russian invasion of Ukraine in February 2022 has dramatically restructured strategic priorities within the global defense sector either by developing innovative defense capabilities, or the re-invigorating previously stagnant market segments. As the geostrategic implications of this conflict continue to reverberate across global markets, the primary lesson learned is the need to upscale production capacity and leverage cost-efficiency across all domains of modern warfare, with investments driving innovation of both technology and operations throughout...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDTX-1535 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDTX-1535 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDTX-1535 in Non-Small Cell Lung Cancer Drug Details: BDTX-1535...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDTX-1535 in Recurrent Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDTX-1535 in Recurrent Glioblastoma Multiforme (GBM) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDTX-1535 in Recurrent Glioblastoma Multiforme (GBM) Drug Details: BDTX-1535...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tipifarnib in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tipifarnib in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tipifarnib in Follicular Lymphoma Drug Details: Tipifarnib (Zarnestra) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tipifarnib in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tipifarnib in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tipifarnib in Chronic Myelocytic Leukemia (CML, Chronic...